The Nation’s Premier Lymphoma-Specific Research Organization Also Adds Four Experts to Industry Leading SAB New York, NY (July 1, 2017) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…
New York, NY (June 5, 2017) – The U.S. Food and Drug Administration (FDA) announced it has approved the use of subcutaneous rituximab (Rituxan ®) to treat patients with previously untreated follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL),…
Local wine and food patrons gather in support of the Lymphoma Research Foundation’s mission Chicago, IL (June 8, 2017) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving…
Applications for 2018 research grants are now open and will be accepted until September The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive…
New York, NY (March 14, 2017) – The U.S. Food and Drug Administration (FDA) announced it has approved the use of pembrolizumab (KEYTRUDA ®) to treat patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after three…
By: Ann LaCasce, MD and Sonali M. Smith, MD The last decade has seen a number of exciting developments in lymphoma research, with new therapies, improved treatment strategies, and a more developed understanding of lymphoma biology improving patient treatment and…
Hans-Guido Wendel, MD (Memorial Sloan Kettering Cancer Center) is a two-time recipient of the Lymphoma Research Foundation’s Follicular Pathways Grant, and a member of LRF’s Scientific Advisory Board. As befits the grant name, Dr. Wendel’s research focuses on the microbiology…
New York, NY (January 6, 2017) – The Lymphoma Research Foundation’s (LRF) CEO, Meghan Gutierrez, was honored to represent the lymphoma community at the White House, during the Cancer Moonshot Open Innovation meeting, to discuss reaching Cancer Moonshot goals. Cancer Moonshot began…
ASH Meeting to Feature Lymphoma Research Foundation Scientific Advisory Board Members and Research Grantees in 2016 New York, NY (December 1, 2016) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma…